What is Drotaverine injection used for?
Pharmaceutical Product Monograph: Drotaverine Hydrochloride Injection (20 mg/mL)
In the pharmaceutical industry, Drotaverine is a benzylisoquinoline derivative and a potent Antispasmodic agent. As a pharmacist and manufacturer, I view this molecule as the “Selective Smooth Muscle Relaxant”—it is technically designed to target the source of internal pain without the “drying” side effects (anticholinergic effects) common in older drugs like Hyoscine or Atropine.
At your WHO-GMP facility in Mumbai, Drotaverine 40 mg (in 2 mL) is a high-volume SKU for Gastroenterology, Urology, and Gynecology portfolios. It is the “gold standard” for relieving acute colicky pain.
Therapeutic Profile: Primary Indications
Drotaverine injection is indicated for the rapid relief of smooth muscle spasms across multiple organ systems.
| Indication | Clinical Context | Technical Rationale |
| Abdominal Colic | Gastroenterology | Relieves spasms associated with gastric/duodenal ulcers, gastritis, and enteritis. |
| Biliary Colic | Hepatology | Used for acute pain from Gallstones (Cholelithiasis) or inflammation of the bile duct. |
| Renal Colic | Urology | The primary emergency treatment for the intense pain caused by Kidney Stones (Nephrolithiasis). |
| Dysmenorrhea | Gynecology | Specifically effective for severe menstrual cramps by relaxing the uterine smooth muscle. |
| Labor Augmentation | Obstetrics | Technically used to shorten the first stage of labor by accelerating cervical dilation (under strict supervision). |
Mechanism: Selective PDE-IV Inhibition
Drotaverine works through a highly specific biochemical pathway that differentiates it from other antispasmodics:
Enzyme Targeting: It acts as a selective inhibitor of the enzyme Phosphodiesterase IV (PDE-IV).
cAMP Accumulation: By blocking PDE-IV, it prevents the breakdown of Cyclic Adenosine Monophosphate (cAMP) within the smooth muscle cells.
Calcium Sequestration: High levels of cAMP lead to a decrease in the uptake of Calcium ions into the cells.
Muscle Relaxation: Without sufficient calcium, the “myosin light chain kinase” cannot be activated, leading to the immediate relaxation of the spasming muscle.
The Pharmacist’s “Technical Warning”
The “No Anticholinergic” USP: As a pharmacist, I must emphasize that Drotaverine does not cause blurred vision, dry mouth, or rapid heart rate. This makes it technically safer for patients with Glaucoma or Prostatic Hyperplasia (BPH) who cannot take Hyoscine.
Rapid IV Injection: If given intravenously, it must be injected very slowly. Rapid IV bolus can technically cause a sudden drop in blood pressure (hypotension) or cardiac arrhythmias.
Porphyria: Drotaverine is technically considered unsafe for patients with a history of acute intermittent porphyria.
Interaction with Levodopa: It may antagonize the effect of Levodopa, potentially worsening tremors in patients with Parkinson’s Disease.
The Manufacturer’s Perspective: Technical & Export
From a production and B2B standpoint at your facility in Mumbai:
The “Clear Solution” USP: On your digital marketplace, highlight your Oxygen-Free Nitrogen Flushing process during ampoule filling. This prevents the oxidation of Drotaverine Hydrochloride, ensuring the solution remains colorless and stable for a 36-month shelf life.
The “Dual-Strength” Strategy: For international B2B tenders, offer both the standard 40 mg/2 mL and the high-potency 80 mg/2 mL ampoules. The 80 mg version is a major technical advantage for ER departments handling severe renal colic.
Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers for Drotaverine 20 mg/mL (2 mL) to support your registration in international B2B tenders for emergency and gastrointestinal medicine.